Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience

Saranya Ravindra; Ravindhi Murphy; Isra Ferjani; James Clark; Dalia Ahmed; Danielle Power; Olivia Hatcher; Waleed Mohammed; Tom Newsom-Davis; Joanne Evans

doi:10.1016/S0169-5002(21)00309-3

Back

Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience

Journal article

Peer reviewed

Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience

Saranya Ravindra, Ravindhi Murphy, Isra Ferjani, James Clark, Dalia Ahmed, Danielle Power, Olivia Hatcher, Waleed Mohammed, Tom Newsom-Davis and Joanne Evans

Lung cancer (Amsterdam, Netherlands), Vol.156, p.S46

06/2021

DOI: https://doi.org/10.1016/S0169-5002(21)00309-3

Metrics

1 Record Views

Details

Title: Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience
Creators - without role: Saranya Ravindra
Ravindhi Murphy
Isra Ferjani
James Clark
Dalia Ahmed
Danielle Power
Olivia Hatcher
Waleed Mohammed
Tom Newsom-Davis
Joanne Evans
Publication Details: Lung cancer (Amsterdam, Netherlands), Vol.156, p.S46
Identifiers: 9921900408331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article